A DNA methylation-based liquid biopsy for triple-negative breast cancer
Abstract Here, we present a next-generation sequencing (NGS) methylation-based blood test called methylation DETEction of Circulating Tumour DNA (mDETECT) designed for the optimal detection and monitoring of metastatic triple-negative breast cancer (TNBC). Based on a highly multiplexed targeted sequ...
Main Authors: | Katrina Cristall, Francois-Clement Bidard, Jean-Yves Pierga, Michael J. Rauh, Tatiana Popova, Clara Sebbag, Olivier Lantz, Marc-Henri Stern, Christopher R. Mueller |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-021-00198-9 |
Similar Items
-
Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
by: Hélène Bonsang-Kitzis, et al.
Published: (2015-01-01) -
Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
by: Hélène Bonsang-Kitzis, et al.
Published: (2016-01-01) -
Clinical utility of circulating tumor cells: an update
by: Antoine Vasseur, et al.
Published: (2021-06-01) -
Prognostic significance of adipophilin expression in biopsy specimens of patients with triple‑negative breast cancer
by: Ishida, M., et al.
Published: (2022) -
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
by: Paul Jank, et al.
Published: (2020-01-01)